News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
848,539 Results
Type
Article (86573)
Company Profile (702)
Press Release (761264)
Multimedia
Podcasts (132)
Webinars (14)
Section
Business (232717)
Career Advice (4128)
Deals (39728)
Drug Delivery (129)
Drug Development (91002)
Employer Resources (198)
FDA (18126)
Job Trends (17342)
News (396541)
Policy (39763)
Tag
Academia (3001)
Academic (2)
Accelerated approval (7)
Adcomms (30)
Allergies (96)
Alliances (56864)
ALS (107)
Alzheimer's disease (1518)
Antibody-drug conjugate (ADC) (166)
Approvals (18074)
Artificial intelligence (348)
Autoimmune disease (30)
Automation (17)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (481)
Bladder cancer (88)
Brain cancer (33)
Breast cancer (325)
Cancer (2558)
Cardiovascular disease (217)
Career advice (3535)
Career pathing (34)
CAR-T (186)
Cell therapy (522)
Cervical cancer (22)
Clinical research (73610)
Collaboration (959)
Company closure (2)
Compensation (599)
Complete response letters (30)
COVID-19 (2876)
CRISPR (57)
C-suite (287)
Cystic fibrosis (111)
Data (2496)
Decentralized trials (2)
Denatured (46)
Depression (58)
Diabetes (311)
Diagnostics (6942)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (157)
Drug pricing (138)
Drug shortages (33)
Duchenne muscular dystrophy (110)
Earnings (97360)
Editorial (47)
Employer branding (25)
Employer resources (167)
Events (130506)
Executive appointments (818)
FDA (19617)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (861)
Gene editing (133)
Generative AI (36)
Gene therapy (389)
GLP-1 (873)
Government (5183)
Grass and pollen (6)
Guidances (174)
Healthcare (20894)
Huntington's disease (26)
IgA nephropathy (32)
Immunology and inflammation (158)
Immuno-oncology (1)
Indications (31)
Infectious disease (3041)
Inflammatory bowel disease (160)
Inflation Reduction Act (12)
Influenza (59)
Intellectual property (106)
Interviews (813)
IPO (17851)
IRA (51)
Job creations (5190)
Job search strategy (2861)
Kidney cancer (11)
Labor market (47)
Layoffs (569)
Leadership (24)
Legal (10120)
Liver cancer (82)
Lung cancer (361)
Lymphoma (169)
Machine learning (9)
Management (65)
Manufacturing (384)
MASH (88)
Medical device (14654)
Medtech (14659)
Mergers & acquisitions (22476)
Metabolic disorders (837)
Multiple sclerosis (93)
NASH (23)
Neurodegenerative disease (126)
Neuropsychiatric disorders (36)
Neuroscience (2167)
NextGen: Class of 2025 (7682)
Non-profit (5084)
Now hiring (42)
Obesity (445)
Opinion (278)
Ovarian cancer (86)
Pain (106)
Pancreatic cancer (91)
Parkinson's disease (172)
Partnered (25)
Patents (268)
Patient recruitment (125)
Peanut (51)
People (65408)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22721)
Phase II (31974)
Phase III (24067)
Pipeline (1530)
Policy (187)
Postmarket research (3552)
Preclinical (10267)
Press Release (72)
Prostate cancer (116)
Psychedelics (39)
Radiopharmaceuticals (271)
Rare diseases (452)
Real estate (7393)
Recruiting (75)
Regulatory (26866)
Reports (61)
Research institute (2661)
Resumes & cover letters (649)
Rett syndrome (7)
RNA editing (8)
RSV (50)
Schizophrenia (84)
Series A (150)
Series B (99)
Service/supplier (30)
Sickle cell disease (61)
Special edition (21)
Spinal muscular atrophy (166)
Sponsored (35)
Startups (4295)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (59)
The Weekly (84)
Vaccines (831)
Venture capitalists (45)
Weight loss (309)
Women's health (42)
Worklife (20)
Date
Today (152)
Last 7 days (908)
Last 30 days (3869)
Last 365 days (35561)
2025 (14078)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (62)
Alaska (7)
Arizona (271)
Arkansas (14)
Asia (50222)
Australia (8844)
California (6977)
Canada (2166)
China (597)
Colorado (299)
Connecticut (316)
Delaware (174)
Europe (115277)
Florida (1018)
Georgia (235)
Hawaii (1)
Idaho (65)
Illinois (662)
India (31)
Indiana (351)
Iowa (13)
Japan (189)
Kansas (115)
Kentucky (28)
Louisiana (16)
Maine (72)
Maryland (1014)
Massachusetts (5319)
Michigan (260)
Minnesota (442)
Mississippi (2)
Missouri (94)
Montana (31)
Nebraska (26)
Nevada (74)
New Hampshire (70)
New Jersey (1939)
New Mexico (31)
New York (1957)
North Carolina (1177)
North Dakota (10)
Northern California (3005)
Ohio (233)
Oklahoma (15)
Oregon (48)
Pennsylvania (1514)
Puerto Rico (15)
Rhode Island (36)
South America (1653)
South Carolina (29)
South Dakota (1)
Southern California (2575)
Tennessee (111)
Texas (1045)
United States (26485)
Utah (205)
Virginia (186)
Washington D.C. (74)
Washington State (634)
West Virginia (3)
Wisconsin (76)
There are 848,539 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
FDA’s New Risk-Based Approach to COVID-19 Vaccines Aims to Ease ‘Public Distrust’: Makary, Prasad
The new framework was well-received by biopharma analysts, who say it “largely formalizes” current COVID-19 vaccination trends.
May 20, 2025
·
4 min read
·
Heather McKenzie
Drug pricing
New Details From Trump’s Drug Pricing Effort Put Branded Drugs in the Crosshairs
Drugmakers will be expected to commit to aligning U.S. prices with the lowest price set in a group of peer nations for all brand products across all markets that do not currently have generic or biosimilar competition.
May 20, 2025
·
1 min read
·
Annalee Armstrong
Rare diseases
CRISPR Success in Single Baby Highlights Rare Disease ‘Crisis’
Most of the 15 million children with a rare disease have no FDA-approved treatments available to them. And when it comes to the most-rare conditions, there isn’t even a pipeline.
May 20, 2025
·
3 min read
·
Dan Samorodnitsky
Press Releases
Hemostemix Presents at TERMIS 2025, Freiburg, Germany
May 20, 2025
·
7 min read
China
Pfizer’s China Deal Worth up to $6B Eclipses Peers in a Frenzied Market
The largest Chinese licensing deal behind Pfizer’s is Novartis’ partnership with Shanghai Argo Biopharma, worth potentially more than $4 billion.
May 20, 2025
·
1 min read
·
Annalee Armstrong
Layoff Tracker
Prime Cuts 25% of Staff, Deprioritizes CGD Programs
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
May 20, 2025
·
208 min read
·
BioSpace Editorial Staff
Press Releases
BioMark Diagnostics Announces Breakthrough Publication Reinforcing Leadership in AI-Powered Metabolomics for Oncology
May 20, 2025
·
5 min read
Opinion
Understanding What Trump’s MFN Executive Order Can and Can’t Do
The Most Favored Nation order is unlikely to deliver broad, sustained savings without triggering legal challenges, administrative friction and unintended consequences for both the healthcare sector and patient access.
May 20, 2025
·
6 min read
·
Robert Albarano
Press Releases
Kura Oncology to Participate in Three Upcoming Investor Conferences in May and June 2025
May 20, 2025
·
2 min read
Press Releases
IO Biotech Announces Participation in Cowen 6th Annual Oncology Innovation Summit and Jefferies Global Healthcare Conference
May 20, 2025
·
4 min read
1 of 84,854
Next
